Eurofins Scientific SE Cash Flow Conversion Efficiency
Eurofins Scientific SE cash flow conversion efficiency. Based on the latest financial reports, Eurofins Scientific SE (ERF) has a cash flow conversion efficiency ratio of 0.220x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€789.60 Million ≈ $923.13 Million USD) by net assets (€3.59 Billion ≈ $4.19 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Eurofins Scientific SE (2002–2025)
Cash flow conversion efficiency of Eurofins Scientific SE from 2002 to 2025. This chart illustrates how Eurofins Scientific SE's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Eurofins Scientific SE (ERF) stock price for real-time trading data and today's change.
Eurofins Scientific SE Cash Flow Conversion Ratio Explained
Eurofins Scientific SE cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Eurofins Scientific SE Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Eurofins Scientific SE ranked by their cash flow conversion efficiency. Also see ERF company net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
The AES Corporation
NYSE:AES
|
0.128x |
|
China Southern Airlines Co Ltd Class A
SHG:600029
|
0.316x |
|
Persistent Systems Limited
NSE:PERSISTENT
|
0.052x |
|
Alcoa Corp
NYSE:AA
|
0.040x |
|
BALOISE HLDG AG ADR/1/10
F:BLO
|
N/A |
|
AtkinsRealis Group Inc
TO:ATRL
|
0.015x |
|
FactSet Research Systems Inc
NYSE:FDS
|
0.102x |
|
China Pacific Insurance (Group) Co. Ltd
F:75C
|
0.102x |
Annual Cash Flow Conversion Efficiency for Eurofins Scientific SE (2002–2025)
The table below shows the annual cash flow conversion efficiency of Eurofins Scientific SE from 2002 to 2025. Review Eurofins Scientific SE free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €3.59 Billion ≈ $4.19 Billion |
€1.29 Billion ≈ $1.51 Billion |
0.361x | +47.44% |
| 2024-12-31 | €5.38 Billion ≈ $6.30 Billion |
€1.32 Billion ≈ $1.54 Billion |
0.245x | +23.62% |
| 2023-12-31 | €5.14 Billion ≈ $6.01 Billion |
€1.02 Billion ≈ $1.19 Billion |
0.198x | -15.41% |
| 2022-12-31 | €4.85 Billion ≈ $5.67 Billion |
€1.14 Billion ≈ $1.33 Billion |
0.234x | -27.44% |
| 2021-12-31 | €4.68 Billion ≈ $5.47 Billion |
€1.51 Billion ≈ $1.77 Billion |
0.323x | -1.95% |
| 2020-12-31 | €3.72 Billion ≈ $4.34 Billion |
€1.22 Billion ≈ $1.43 Billion |
0.329x | +40.74% |
| 2019-12-31 | €2.90 Billion ≈ $3.39 Billion |
€677.90 Million ≈ $792.54 Million |
0.234x | +17.07% |
| 2018-12-31 | €2.72 Billion ≈ $3.18 Billion |
€543.89 Million ≈ $635.87 Million |
0.200x | +22.41% |
| 2017-12-31 | €2.48 Billion ≈ $2.90 Billion |
€405.12 Million ≈ $473.63 Million |
0.163x | -22.89% |
| 2016-12-31 | €1.76 Billion ≈ $2.05 Billion |
€371.84 Million ≈ $434.72 Million |
0.212x | -21.46% |
| 2015-12-31 | €1.08 Billion ≈ $1.26 Billion |
€291.15 Million ≈ $340.38 Million |
0.270x | -15.63% |
| 2014-12-31 | €664.24 Million ≈ $776.57 Million |
€212.17 Million ≈ $248.05 Million |
0.319x | -25.54% |
| 2013-12-31 | €394.74 Million ≈ $461.49 Million |
€169.34 Million ≈ $197.97 Million |
0.429x | +20.27% |
| 2012-12-31 | €376.12 Million ≈ $439.73 Million |
€134.16 Million ≈ $156.85 Million |
0.357x | +3.57% |
| 2011-12-31 | €320.31 Million ≈ $374.48 Million |
€110.32 Million ≈ $128.98 Million |
0.344x | -6.46% |
| 2010-12-31 | €230.69 Million ≈ $269.70 Million |
€84.94 Million ≈ $99.30 Million |
0.368x | +16.19% |
| 2009-12-31 | €203.03 Million ≈ $237.37 Million |
€64.34 Million ≈ $75.22 Million |
0.317x | +15.65% |
| 2008-12-31 | €219.12 Million ≈ $256.17 Million |
€60.04 Million ≈ $70.19 Million |
0.274x | +49.26% |
| 2007-12-31 | €215.56 Million ≈ $252.02 Million |
€39.57 Million ≈ $46.26 Million |
0.184x | -37.57% |
| 2006-12-31 | €102.64 Million ≈ $119.99 Million |
€30.18 Million ≈ $35.28 Million |
0.294x | -4.93% |
| 2005-12-31 | €82.42 Million ≈ $96.35 Million |
€25.49 Million ≈ $29.80 Million |
0.309x | -12.53% |
| 2004-12-31 | €66.10 Million ≈ $77.28 Million |
€23.37 Million ≈ $27.32 Million |
0.354x | +44.47% |
| 2003-12-31 | €53.85 Million ≈ $62.96 Million |
€13.18 Million ≈ $15.41 Million |
0.245x | +12.56% |
| 2002-12-31 | €52.91 Million ≈ $61.86 Million |
€11.51 Million ≈ $13.45 Million |
0.217x | -- |
About Eurofins Scientific SE
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. It provides services, such as agroscience, including biological assessment, consumer and human, environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, including sustainability, audit, certification, quality inspection,… Read more